USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER - REPLY

被引:0
|
作者
PARTIN, AW
YOO, J
CARTER, HB
PEARSON, JD
CHAN, DW
EPSTEIN, JI
WALSH, PC
机构
来源
JOURNAL OF UROLOGY | 1993年 / 150卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1924 / 1924
页数:1
相关论文
共 50 条
  • [1] THE USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER
    ROACH, M
    JOURNAL OF UROLOGY, 1993, 150 (06): : 1923 - 1924
  • [2] THE USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER
    PARTIN, AW
    WALSH, PC
    JOURNAL OF UROLOGY, 1994, 152 (01): : 172 - 173
  • [3] THE USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER
    PARTIN, AW
    YOO, J
    CARTER, HB
    PEARSON, JD
    CHAN, DW
    EPSTEIN, JI
    WALSH, PC
    JOURNAL OF UROLOGY, 1993, 150 (01): : 110 - 114
  • [4] Combination of prostate-specific antigen, clinical stage, and gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update
    Partin, AW
    Kattan, MW
    Subong, ENP
    Walsh, PC
    Wojno, KJ
    Oesterling, JE
    Scardino, PT
    Pearson, JD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1445 - 1451
  • [5] Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer - A multi-institutional update
    Partin, AW
    Kattan, MW
    Subong, EN
    Walsh, PC
    Wojno, KJ
    Oesterling, JE
    Scardino, PT
    Pearson, JD
    Graefen, M
    AKTUELLE UROLOGIE, 2004, 35 (05) : 377 - 378
  • [6] Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update (vol 277, pg 1445, 1997)
    Partin, AW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (02): : 118 - 118
  • [7] PROSTATE-SPECIFIC ANTIGEN - CLINICAL VERSUS PATHOLOGICAL STAGE - REPLY
    DIAZ, AZ
    ROACH, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (02): : 501 - 501
  • [8] SERUM PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE, PATHOLOGICAL GRADE, AND THE INCIDENCE OF NODAL METASTASES IN PROSTATE-CANCER
    SANDS, ME
    ZAGARS, GK
    POLLACK, A
    VONESCHENBACH, AC
    UROLOGY, 1994, 44 (02) : 215 - 220
  • [9] Prostate-specific antigen velocity and prostate cancer Gleason grade and stage
    Pinsky, Paul F.
    Andriole, Gerald
    Crawford, E. David
    Chia, David
    Kramer, Barnett S.
    Grubb, Robert
    Greenlee, Robert
    Gohagan, John K.
    CANCER, 2007, 109 (08) : 1689 - 1695
  • [10] Value of percent free prostate-specific antigen for the prediction of pathological stage in men with clinically localized prostate cancer
    Morote, J
    Trilla, E
    Esquena, S
    Serrallach, F
    Abascal, JM
    H'Mammed, YI
    de Torres, IM
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (04): : 239 - 243